Research in Motion Ltd (NASDAQ:BBRY) Continued to Move Higher - PLX, BBRY, HEB, SWY, RIM

Lakeway, TX -- (SBWIRE) -- 02/06/2013 -- Bestdamnpennystocks, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-

Protalix BioTherapeutics Inc. (NYSE:PLX) soared 15% following an Israeli report that Pfizer has shown an interest in buying the company after it hired Citigroup to start a sale process. Protalix is angling for $1B, double its market cap, although Pfizer doesn't want to pay that much, while an offer of $700-800M could be enough to sway Protalix's largest shareholders. The companies already partner for the marketing of Protalix's Elelyso drug for Gaucher disease.

Is OPXA after A Solid Pop Up? Find Out Here

Research In Motion Ltd (NASDAQ:BBRY) continues its roller-coaster ride, rallying again today on optimism about early Z10 sales. "We believe BlackBerry’s Z10 is off to a better start than the Lumia 920," says Barclays' Jeff Kvaal after conducting U.K. store checks. That might not be an ideal comparison, since the 920 was supply-constrained at launch time. Deutsche's checks indicate U.K. carriers aren't actively promoting the Z10. The stock rose another 7% in Tuesday’s session.

Will BBRY Continue To Trend Higher After The Recent Gain? Find Out Here

Hemispherx BioPharma, Inc (NYSE:HEB) plummeted 14.70% after the FDA again rejects Ampligen, its treatment for chronic fatigue syndrome. As the agency initially said when it first rejected the drug in 2009, it wants Hemispherx to carry out another trial, as the submitted data doesn't provide enough evidence of Ampligen's efficacy or safety. Hemispherx intends to appeal.

Is HEB a Buy Opportunity After The Recent Slump? Find Out Here

Safeway Inc. (NYSE:SWY)’s move to hire a real estate specialist to be its new CFO could spark a fresh round of speculative chatter that the company is interested in monetizing its real estate assets, notes dealReporter. Though the company is quiet on the issue of creating a real estate investment trust, a scan of Peter Bocian's resume speaks volumes.

Is NFLX Still a Buy After The Recent momentum? Find Out Here

About bestdamnpennystocks.com
Best Damn Penny Stocks’ team is engaged in providing stock newsletters on various hot penny stocks on a regular basis. Our instant stock news on Major Gainers, small cap penny stocks and various other stocks, guides investors in making the wise stock market investments decision. In order to get update to the markets, we would advise you sign up to our free newsletters. You can become leader in stock market by keeping track of the daily activity.

Disclaimer
The assembled information disseminated by Bestdamnpennystocks.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Bestdamnpennystocks.com does expect that investors will buy and sell securities based on information assembled and presented in Bestdamnpennystocks.com. PLEASE always do your own due diligence, and consult your financial advisor.